activ
immun
effect
mean
block
pharmacodynam
effect
drug
hold
promis
treatment
heroin
addict
previous
demonstr
efficaci
firstgener
vaccin
block
heroin
selfadministr
rat
howev
mani
vaccin
compon
modifi
improv
perform
herein
examin
effect
vari
heroin
vaccin
inject
rout
adjuv
formul
mice
immun
via
subcutan
sc
inject
exhibit
inferior
antiheroin
titer
compar
intraperiton
ip
scip
coadministr
inject
rout
addit
agonist
cytosineguanin
oligodeoxynucleotid
cpg
odn
origin
alum
adjuv
elicit
superior
antibodi
titer
opioid
affin
compar
alum
alon
thoroughli
assess
vaccin
efficaci
full
curv
gener
heroininduc
analgesia
hot
plate
tail
immers
test
mice
treat
cpg
odn
exhibit
greatli
shift
curv
vs
unvaccin
control
noncpg
odn
vaccin
group
exhibit
robust
effect
shift
ip
combo
shift
sc
result
suggest
cpg
odn
highli
potent
adjuv
inject
rout
consid
develop
small
conjug
vaccin
lastli
studi
establish
new
standard
assess
drug
abus
vaccin
wherein
full
curv
perform
appropri
behavior
task
heroin
highli
addict
semisynthet
opioid
deriv
diacetyl
morphin
inde
heroin
abus
signific
problem
incur
larg
social
econom
cost
worldwid
alarmingli
number
heroin
user
us
grown
furthermor
sinc
number
death
due
heroin
overdos
also
increas
due
sever
heroin
addict
dire
need
antiheroin
addict
treatment
effect
current
avail
pharmacolog
agent
eg
methadon
buprenorphin
naltrexon
first
report
work
heroin
vaccin
disclos
howev
research
heroin
immunopharmacotherapi
conduct
past
decad
previous
report
design
keyhol
limpet
hemocyanin
immunoconjug
figur
show
ampl
promis
combin
alum
adjuv
vaccin
heroin
addict
testament
vaccin
efficaci
immun
heroindepend
rat
prevent
relaps
compuls
intak
heroin
selfadministr
model
herein
sought
improv
vaccin
perform
inject
rout
adjuv
explor
vaccin
administr
rout
may
influenc
immun
respons
due
differ
physiolog
environ
subcutan
tissu
versu
periton
caviti
interestingli
studi
date
investig
inject
rout
small
molecul
conjug
vaccin
addit
administr
rout
adjuv
also
impact
vaccin
perform
capac
tlr
agonist
could
play
import
role
vaccin
design
abil
modul
immun
respons
exampl
cpg
odn
act
pathogen
associ
molecular
pattern
pamp
stimul
innat
immun
receptor
specif
cpg
odn
cpg
figur
member
bclass
odn
activ
bcell
immun
respons
impress
vaccin
trial
engag
specif
cpg
odn
sequenc
combin
alum
demonstr
abil
safe
enhanc
igg
antibodi
titer
target
antigen
mice
lymphoma
result
clinic
studi
demonstr
cpg
odn
efficaci
enhanc
immun
target
antigen
display
favor
safeti
profil
addit
adjuv
inexpens
stabl
readili
obtain
easili
manipul
vaccin
formul
cpg
odn
therefor
hold
promis
adjunct
heroin
vaccin
cocktail
mean
potenti
opioidneutr
antibodi
research
disclos
herein
inject
rout
agonist
cpg
odn
significantli
affect
antibodi
titer
level
opiat
affin
translat
mark
differ
mitig
heroininduc
analgesia
full
heroin
respons
curv
gener
hotplat
tail
flick
test
clearli
demonstr
differ
vaccin
efficaci
result
widereach
applic
refin
evalu
drug
abus
vaccin
studi
perform
complianc
scripp
insitut
anim
care
use
committe
concord
nation
institut
health
guid
care
use
laboratori
anim
week
old
male
swiss
webster
mice
tacon
immun
ip
sc
ipsc
conjug
day
mice
bled
day
sinc
titer
much
higher
day
day
sera
use
report
immunochem
assay
figur
prepar
via
coupl
conjug
prepar
surrog
quantifi
hapten
load
malditof
ms
copi
per
bsa
support
inform
perform
previous
singl
batch
conjug
use
immun
vaccin
prepar
shake
vv
mixtur
imject
alum
thermo
pierc
min
final
volum
inject
per
mous
oligonucleotid
adjuv
group
phosphorothio
cpg
odn
figur
eurofin
mwg
operon
adsorb
alum
alongsid
mous
receiv
odn
per
inject
ip
elisa
elisa
plate
coat
ngml
conjug
overnight
ph
pb
buffer
use
throughout
assay
titer
report
od
overal
titer
determin
iggigmiga
secondari
southernbiotech
igg
titer
determin
secondari
specif
invitrogen
competit
elisa
limit
dilut
found
normal
titer
curv
treatment
group
pool
sera
choos
dilut
produc
maximum
absorb
competit
heroin
primari
metabolit
morphin
cambridg
isotop
run
triplic
group
dmso
use
solubil
opioid
final
assay
dmso
concentr
gener
competit
elisa
ic
valu
underestim
actual
k
factor
radioimmunoassay
determin
k
possibl
instabl
heroin
hot
plate
tail
immers
antinocicept
test
day
mice
test
spinal
tail
immers
supraspin
hot
plate
antinocicept
respons
set
hot
plate
test
measur
place
mous
acryl
cylind
cm
diamet
cm
time
latenc
perform
one
follow
nocicept
respons
lick
hindpaw
shake
hindpaw
jump
mice
remov
surfac
immedi
follow
respons
typic
baselin
latenc
cutoff
prevent
tissu
damag
tail
immers
test
administ
lightli
restrain
mice
small
pouch
construct
absorb
laboratori
underpad
dip
cm
tip
tail
heat
water
bath
time
withdraw
time
typic
baselin
respons
cutoff
impos
prevent
tissu
damag
baselin
hot
plate
follow
tail
flick
perform
drug
immedi
administ
follow
set
time
min
heroin
min
morphineoxycodon
test
repeat
full
analges
respons
note
anim
continu
receiv
cumul
drug
inject
repeat
test
cutoff
time
reach
drug
test
counterbalanc
manner
least
day
drug
cumulativedos
regimen
comput
analysi
comput
statist
analysi
perform
graphpad
prism
valu
report
mean
sem
titer
determin
appli
one
site
fit
nonlinear
regress
normal
perform
fit
titer
curv
one
site
fit
regress
express
valu
percentag
maximum
absorb
competit
curv
gener
limit
dilut
first
normal
fit
log
inhibitor
vs
normal
respons
variabl
slope
regress
calcul
ic
valu
titer
compar
via
oneway
anova
fisher
lsd
post
hoc
comparison
antinocicept
data
transform
time
maximum
possibl
effect
mpe
calcul
mpe
test
baselin
cutoff
baselin
data
fit
use
log
agonist
vs
normal
respons
nonlinear
regress
produc
ed
valu
drug
pain
test
individu
treatment
group
allow
calcul
potenc
ratio
differ
potenc
determin
oneway
anova
follow
tukey
post
hoc
test
antibodi
titer
opioid
affin
mice
immun
first
gener
heroin
vaccin
klh
conjug
formul
alum
adjuv
antibodi
titer
measur
elisa
conjug
signific
effect
vaccin
antibodi
titer
observ
f
p
f
p
ip
ipsc
administr
heroin
vaccin
gave
nearli
ident
titer
higher
compar
sc
inject
tabl
top
signific
effect
ip
administr
rout
compar
sc
addit
cpg
odn
increas
titer
compar
alum
alon
p
fisher
test
base
upon
competit
elisa
data
ip
group
exhibit
poorest
overal
opioid
affin
although
ipsc
group
affin
weakest
group
tabl
contrast
affin
heroin
morphin
better
sc
group
cpg
odn
ad
exist
formul
affin
improv
heroin
morphin
statist
comparison
perform
affin
determin
pool
sera
assess
humor
respons
compar
titer
antiheroin
respect
shown
previous
heroin
vaccin
exhibit
exclus
immun
respons
howev
addit
cpg
odn
current
studi
elicit
robust
humor
respons
indic
increas
titer
tabl
p
furthermor
cpg
odn
enhanc
humor
respons
boost
titer
alum
alon
p
antinocicept
test
assess
vaccin
perform
block
analges
effect
heroin
vaccin
anim
subject
two
antinocicept
test
hot
plate
tail
immers
full
curv
correspond
ed
valu
gener
thoroughli
test
vaccin
efficaci
wide
rang
heroin
dose
repeat
select
morphin
oxycodon
result
behavior
test
gener
parallel
elisa
result
vaccin
show
vari
degre
shift
heroin
antinocicept
right
tail
immers
respons
vaccin
figur
signific
effect
vaccin
observ
base
deriv
estim
heroin
tabl
tabl
tukey
test
ip
ipsc
perform
fairli
similar
one
anoth
gave
ed
valu
better
naiv
anim
p
addit
cpg
odn
increas
ed
valu
hot
plate
p
tail
immers
p
alum
alon
similar
antinocicept
test
conduct
morphin
heroin
signific
vaccin
anova
determin
hot
plate
f
p
tail
immers
f
p
similar
previou
find
origin
vaccin
formul
primarili
effect
heroin
morphin
signific
shift
morphin
potenc
found
compar
naiv
regardless
rout
administr
tabl
support
inform
howev
addit
cpg
odn
provid
suffici
boost
titer
affin
gener
signific
reduct
morphin
potenc
though
tail
immers
test
p
expect
confirm
select
vaccin
heroin
primari
metabolit
heroin
vaccin
treatment
provid
protect
oxycodon
structur
similar
opioid
tabl
support
inform
current
studi
highlight
impact
vari
inject
rout
first
gener
heroin
vaccin
along
enhanc
immunogen
addit
cpg
odn
adjuv
studi
directli
compar
inject
rout
drug
abus
vaccin
except
one
studi
found
intraderm
id
nicotin
vaccin
deliveri
effect
compar
intramuscular
im
howev
id
deliveri
gener
compat
alum
adjuv
necessari
compon
heroin
vaccin
although
im
rout
investig
current
studi
previou
studi
shown
im
compar
sc
term
vaccin
immunogen
alum
shown
stimul
dendrit
cell
dc
intraperiton
subcutan
inflammasom
enhanc
immun
respons
antigen
although
respons
observ
ip
sc
administr
rout
titer
higher
ip
differ
physiolog
environ
subcutan
tissu
periton
caviti
may
contribut
observ
discrep
ip
versu
sc
immun
immunogen
periton
fluid
drain
directli
lymph
node
immun
recognit
howev
larg
particl
size
immunogen
formul
alum
prevent
immedi
drainag
subcutan
tissu
consequ
immunogen
taken
dc
transport
lymph
node
evok
adapt
immun
respons
accord
studi
immunogen
immunogen
best
achiev
via
intraperiton
administr
possibl
due
immedi
drainag
lymph
node
sum
find
stress
need
test
vaccin
rout
studi
drug
abus
vaccin
could
especi
import
clinic
level
previous
report
reduc
immunogen
heroin
vaccin
presenc
cpg
odn
howev
result
deriv
oligonucleotid
nativ
phosphodiest
linkag
current
studi
employ
nucleaseresist
phosphorothio
linkag
base
pair
enhanc
vivo
stabil
result
obtain
drastic
increas
titer
opioid
affin
similar
previou
studi
show
cpg
odn
bolster
antinicotin
vaccin
efficaci
interestingli
observ
mark
increas
titer
also
previou
studi
associ
antibodi
boost
cpg
odn
observ
dualli
enhanc
humor
respons
highlight
uniqu
compat
vaccin
cocktail
conjug
alum
cpg
odn
compar
titer
opioid
affin
pain
curv
current
studi
reveal
immunochem
assay
result
alway
present
clear
indic
vaccin
efficaci
especi
vaccin
heroin
target
three
differ
opioid
sc
immun
group
exhibit
higher
opioid
affin
lower
titer
analgesia
test
demonstr
efficaci
sc
group
inferior
group
although
noncpg
group
appear
differ
term
titer
affin
hot
plate
test
reveal
differ
group
lack
efficaci
hot
plate
test
compar
tail
immers
suggest
differenti
abil
block
spinal
reflex
analgesia
larg
mediat
spinal
receptor
versu
complex
painrel
behavior
hot
plate
involv
peripher
spinal
supraspin
process
hot
plate
test
also
found
less
sensit
compar
tail
flick
reduc
morphineinduc
analges
properti
receptor
defici
mice
also
note
compar
previou
titer
hot
plate
evalu
rat
use
vaccin
procedur
mice
exhibit
lower
titer
respons
less
substanti
shift
heroin
hot
plate
analgesia
larg
enhanc
vaccin
perform
cpg
odn
suggest
assess
vaccin
greater
antidrug
titer
affin
must
achiev
also
present
improv
efficaci
behavior
level
moreov
previou
evid
demonstr
weak
blockad
drugdirect
vaccin
tend
actual
promot
increas
drug
seek
often
lead
subject
adjust
dose
order
supersed
vaccin
necessit
rigor
behavior
test
wide
rang
dose
provid
accur
indic
vaccin
efficaci
reduc
drug
psychoact
shown
enhanc
antidrug
titer
opioid
affin
cpg
odn
translat
directli
reduc
pharmacodynam
drug
case
heroininduc
latenc
nocicept
analgesia
greatli
diminish
hot
plate
tail
immers
test
previou
studi
shown
cpg
odn
use
adjuv
nicotin
vaccin
greater
degre
drug
immunoantagon
achiev
antibodi
vaccin
anim
bind
greater
amount
nicotin
blood
lead
lower
concentr
nicotin
brain
howev
clear
degre
result
would
manifest
behavior
analgesia
test
robust
method
measur
degre
heroin
gener
psychoact
effect
anim
therefor
highli
relev
screen
vaccin
immunotherapeut
antagon
demonstr
previous
blunt
analges
respons
heroin
mice
vaccin
first
gener
heroin
vaccin
correspond
blockad
compuls
heroin
intak
rat
greater
ed
heroin
analgesia
cpg
odn
vaccin
group
first
gener
vaccin
group
alum
alon
impli
cpg
odn
addit
vaccin
lend
signific
increas
protect
heroin
addict
extrapol
tail
immers
test
result
human
kg
adult
immun
standard
vaccin
would
administ
mg
heroin
experi
effect
compar
mg
unvaccin
adult
cpg
odn
ad
vaccin
adult
would
administ
mg
heroin
experi
equival
effect
larg
dose
requir
psychoact
maintain
heroin
addict
would
like
becom
impract
behavior
econom
overal
find
studi
expect
facilit
develop
vaccin
opioid
also
drug
abus
tabl
tabul
antinocicept
potenc
morphin
oxycodon
respect
variou
vaccin
treatment
malditof
spectra
conjug
materi
avail
free
charg
via
internet
http
pubsacsorg
